FACTOR B AND C2 PROTEIN POINT MUTANTS, A METHOD FOR ENHANCING THE ACTIVITY OF ANTI- CANCER ANTIBODIES, THE PHARMACEUTICAL COMPOSITION AND THE USE OF MUTANTS

Gdański Uniwersytet Medyczny
FACTOR B AND C2 PROTEIN POINT MUTANTS, A METHOD FOR ENHANCING THE ACTIVITY OF ANTI- CANCER ANTIBODIES, THE PHARMACEUTICAL COMPOSITION AND THE USE OF MUTANTS
Patenty / Zgłoszenia patentoweKnow-how
Jednostki naukowe: Gdański Uniwersytet Medyczny
Numer zgłoszenia / patentu: Pl237868; PCT/PL2019/00002 ; USAppl.np.17/045058
Proposed solution:
• Enhancing anti-cancer activity of therapeutic
antibodies
• New drug candidate of biological origin
• New therapies based on factor B and C2 protein

Contact the Technology Broker
Technology Transfer Office, Medical University of Gdansk

tel. +48 58 349 10 09, 58 349 11 85

e-mail: naukaibiznes@gumed.edu.pl

logo-gumed-male.jpg

Pliki do pobrania

Czy wyrażasz zgodę na przechowywanie cookies przez pactt.pl?

Zapisano